The AI in life science analytics market was valued at USD 1.6 billion in 2024 and is projected to reach USD 4.9 billion by 2035, growing at a CAGR of 10.9% from 2025 to 2035. This growth is driven by the increasing integration of artificial intelligence in drug discovery, clinical trials, and precision medicine, along with rising demand for data-driven insights to enhance research efficiency and accelerate innovation in the life sciences sector.

👉 Get sample market research report copy today@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86873

Market Overview

The AI in the life science analytics market is one of the fastest-growing segments of the healthcare and biotechnology industries. It is a field where AI technologies are progressively employed to get insightful data from complicated and large biological data. The market refers to the use of advanced analytics, machine learning, and predictive modeling in various areas of life sciences such as drug discovery, genomics, clinical research, and patient care management.

With Al, data analysis is automated, and pattern recognition is enhanced. Researchers and organizations can thus innovate at a faster pace, increase precision, and at the same time, make well-informed decisions all along the product development lifecycle. The massive amounts of healthcare and biological data, in addition to the demand for quick, data-based solutions, are the main reasons for the worldwide life sciences industry to get extensively involved in AI-powered analytics.

Analysts’ Viewpoint on the AI Life Science Analytics Market

The global AI in life science analytics market is bound to witness rapid growth over the years due to the rapid digital transformation of the pharma, biotech, and healthcare sectors. It is expected that the integration of AI in life science analytics will significantly impact the way companies decipher complex biological and clinical data, with the whole process being much faster and more accurate results being generated.

AI-powered analytics platforms are expected to be the major enablers of the life science sector in the near future as companies are putting more effort into improving drug discovery efficiency, optimizing clinical trials, and enhancing patient outcomes through data-driven insights. Additionally, the market growth will be fueled by the increasing focus on personalized medicine as well as the numerous collaborations between technology providers and life science companies.

Analysis of Key Players in the Market

The market is defined by strategic partnerships between “Big Tech” infrastructure and “Life Science” domain experts.

Leading companies operating in the global market include:

• Indegene
• Lexalytics
• Databricks
• SAS Institute Inc.
• IQVIA
• IBM
• Sorcero, Inc.
• Axtria
• Medidata
• Sisense Ltd.
• TempusAI, Inc.
• Oracle
• Accenture
• Parexel International (MA) Corporation
• Microsoft
• Other Prominent Players

Recent Developments in AI Life Science Analytics

• In September 2025, Inovalon launched a new data and analytics offering on Snowflake’s AI Data Cloud for Healthcare & Life Sciences. This partnership provides payers and life sciences organizations secure, near real-time access to Inovalon’s primary source data and advanced analytics.
• In January 2024, Cleveland Clinic and IBM researchers released a strategy using AI for identifying new immunotherapy targets. This marks the initial peer-reviewed publication stemming from their Discovery Accelerator partnership, which aims to upgrade healthcare and life sciences research.
• In April 2024, IQVIA and Salesforce announced broadening their global partnership to hasten the development of the Life Sciences Cloud. This collaboration integrates IQVIA OCE innovations with Salesforce’s platform, offering customers a comprehensive engagement solution.
• In June 2024, Medidata introduced Clinical Data Studio, a comprehensive platform that consolidates data from both – Medidata and external sources. This technology enables stakeholders to manage data quality effectively, expedite trial processes, and make quicker decisions by providing a complete view of data and risk strategies.

👉 Discuss Implications for Your Industry Request Sample Research Report PDF@ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=86873

Key Market Trends & Strategies

🤖 The Emergence of Agentic AI

In 2026, AI is no longer just a “recommendation” engine. “Agentic AI” systems are being deployed to autonomously perform complex tasks, such as managing clinical trial recruitment pipelines or adjusting supply chains based on real-world demand signals.

📈 Market Challenges

• The “Skills Gap”: Nearly 50% of life science organizations report that their workforce is currently unprepared for full-scale digital transformation, leading to a surge in demand for AI consulting services.
• Regulatory Compliance: The staged roll-out of the EU AI Act (with key milestones in 2025 and 2026) is forcing companies to rebuild AI architectures to ensure auditability and traceability.

🌟 Growth Opportunities

• Precision Diagnostics: Using AI to analyze Real-World Evidence (RWE) and genomic data to identify patient sub-populations for targeted therapies.
• Next-Gen Molecular Design: Using “Foundation Models” in biology to design entirely new proteins or molecules with specific binding affinities and zero off-target toxicity.

Market Segmentation

By Component

• Software
• Hardware
• Services

By Deployment

• Cloud
• On Premise

By Application

• Research and Development
• Supply Chain Analytics
• Others

By End-user

• Medical Devices Manufacturers
• Pharmaceutical and Biotechnology Companies
• Others

Regional Outlook

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Conclusion

By 2026, AI in life science analytics has transitioned from a competitive advantage to a survival necessity. With the ability to reduce drug discovery times by 30% to 40%, AI is the primary tool for managing the escalating costs and complexities of modern medicine. As regulatory bodies provide clearer frameworks for AI use, the focus for life science leaders must shift from “if” they should use AI to “how” they can build the clean, agent-ready data foundations required to lead in the age of autonomous research.

👉 To buy this comprehensive market research report, click here to inquire@ https://www.transparencymarketresearch.com/checkout.php?rep_id=86873&ltype=S

FAQs

• How big was the global AI in life science analytics market in 2024?

The global AI in life science analytics market was valued at US$ 1.6 Bn in 2024

• How big will the global AI in life science analytics industry be in 2035?

The global AI in life science analytics industry is projected to reach more than US$ 4.9 Bn by the end of 2035

• What are the factors driving the AI in life science analytics market?

Drug discovery and development and demand for treating complex diseases are some of the factors driving the expansion of AI in life science analytics market.

• What will be the CAGR of the global AI in life science analytics industry during the forecast period?

The CAGR is anticipated to be 10.9 % from 2025 to 2035

• Which region will account for a major share of the AI in life science analytics sector during the forecast period?

North America is expected to account for the largest share from 2025 to 2035

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Abhishek Budholiya
Transparency Market Research Inc.
State Tower, 90 State Street, Suite 700,
Albany NY – 12207, United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Sales Inquiries: sales@transparencymarketresearch.com
Media Inquiries: media@transparencymarketresearch.com